Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids
1.0.0 - STU 1 United States of America flag

Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cdc-opioid-cpg/ and changes regularly. See the Directory of published versions

Profiles

Page standards status: Informative

This page provides listings of the various profiles defined in this implementation guide, organized from different perspectives:

  1. By Recommendation: Lists the profiles used in each recommendation
  2. By Subroutine: Lists the profiles used in each subroutine
  3. By Resource: Lists the profiles by Resource

Note that the profiles defined in this implementation guide are computability profiles, meaning that they are focused on identifying the elements involved in calculating logic. It is expected that these profiles will be used in combination with interoperability profiles, and this guide derives from US Core profiles for that purpose.

Profiles by Recommendation

The following table lists the profiles associated with each recommendation in the 2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide

Recommendation Profiles
Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration Opioid Order for Acute Pain (subroutine)
Opioid Review Indicated (subroutine)
Opioid Naive (subroutine)
Recommendation #2 - Prioritize Nonopioid Pain Therapies Opioid Order for Subacute or Chronic Pain (subroutine)
Opioid Review Indicated (subroutine)
Opioid Naive (subroutine) Pain Management Procedure
Pain Treatment Plan
Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy Extended Release Opioid MedicationRequest
Opioid Review Indicated (subroutine)
Opioid Naive (subroutine)
Recommendations #4 and #5 - Lowest Effective Dose MME MedicationRequest
Opioid Review Indicated (subroutine)
Recommendation #6 - Prescribe Lowest Effective Dose and Duration Opioid Order for Acute Pain (subroutine)
Opioid Review Indicated (subroutine)
Recommendation #7 - Opioid Therapy Risk Assessment Opioid Order for Subacute or Chronic Pain (subroutine)
Opioid Review Indicated (subroutine)
Opioid Misuse Assessment Procedure
Recommendation #8 - Naloxone Consideration Opioid Order (subroutine)
Opioid Review Indicated (subroutine)
Naloxone MedicationRequest
Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions Opioid Order (subroutine)
Opioid Review Indicated (subroutine)
PDMP Review Observation
PDMP Review Procedure
Recommendation #10 - Urine Drug Testing Opioid Order for Subacute or Chronic Pain (subroutine)
Opioid Review Indicated (subroutine)
Urine Drug Screening Result Observation
Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines Opioid Order (subroutine)
Benzodiazepine MedicationRequest
CNS Depressant MedicationRequest
Opioid Review Indicated (subroutine)
Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder Opioid Review Indicated (subroutine)
Buprenorphine MedicationRequest
Methadone MedicationRequest

Profiles by Subroutine

The following table lists the profiles associated with each subroutine in the 2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide.

Subroutines are common logic that is shared by multiple recommendations. Each subroutine is linked from the recommendation that uses it in the table above.

Subroutine Profiles
Opioid Review Indicated (i.e. General Inclusion Criteria) Opioid Review Indicated Patient
Opioid Review Indicated Encounter
    Sickle Cell Exclusion Sickle Cell Encounter Diagnosis
Sickle Cell Problem List Item
    End of Life Exclusion End of Life Encounter Diagnosis
End of Life Problem List Item
Active Cancer Treatment Exclusion Active Cancer Encounter Diagnosis
Active Cancer Problem List Item
Opioid Order Opioid MedicationRequest
Opioid Order for Acute Pain Acute Pain Management MedicationRequest Profile
Opioid Order for Subacute or Chronic Pain Subacute or Chronic Pain Management MedicationRequest
Opioid Naive Opioid MedicationRequest

Profiles by Resource

The following listing details the profiles by resource and derivative hierarchy.

Note that implementation experience with these profiles indicates that the MedicationDispense and MedicationStatement resources are not available via the FHIR APIs where this decision support has been integrated. As such, the implementation guide focuses on the use of MedicationRequest resources. This is an especially relevant consideration for recommendation #9 which would greatly benefit from being able to characterize dispensing information. We seek implementer feedback on whether and when MedicationDispense and MedicationStatement information might be available.

All Profiles Index

  • Active Cancer Encounter Diagnosis Condition Profile
  • Active Cancer Problem List Health Concern Condition Profile
  • Acute Pain Management MedicationRequest Profile
  • Amphetamine Medication Profile
  • Amphetamine MedicationRequest Profile
  • Amphetamine Urine Drug Screening Result Observation Profile
  • Barbiturate Medication Profile
  • Barbiturate MedicationRequest Profile
  • Barbiturate Urine Drug Screening Result Observation Profile
  • Benzodiazepine Medication Profile
  • Benzodiazepine MedicationRequest Profile
  • Benzodiazepine Urine Drug Screening Result Observation Profile
  • Buprenorphine Medication Profile
  • Buprenorphine MedicationRequest Profile
  • Buprenorphine Urine Drug Screening Result Observation Profile
  • CNS Depressant Medication Profile
  • CNS Depressant MedicationRequest Profile
  • Cannabinoid Urine Drug Screening Result Observation Profile
  • Chronic Pain Management MedicationRequest Profile
  • Cocaine Urine Drug Screening Result Observation Profile
  • End of Life Encounter Diagnosis Profile
  • End of Life Problem List Health Concern Condition Profile
  • Extended Release Opioid Medication Profile
  • Extended Release Opioid MedicationRequest Profile
  • Fentanyl Medication Profile
  • Fentanyl MedicationRequest Profile
  • Fentanyl Urine Drug Screening Result Observation Profile
  • Heroin Urine Drug Screening Result Observation Profile
  • MME MedicationRequest Profile
  • Methadone Medication Profile
  • Methadone MedicationRequest Profile
  • Methadone Urine Drug Screening Result Observation Profile
  • Naloxone Medication Profile
  • Naloxone MedicationRequest Profile
  • Opiate Medication Profile
  • Opiate MedicationRequest Profile
  • Opiate Urine Drug Screening Result Observation Profile
  • Opioid Medication Profile
  • Opioid MedicationRequest Profile
  • Opioid Misuse Assessment Procedure Profile
  • Opioid Review Indicated Patient Encounter Encounter Profile
  • Opioid Review Indicated Patient MedicationRequest Profile
  • Opioid Review Indicated Patient Profile
  • Oxycodone Medication Profile
  • Oxycodone MedicationRequest Profile
  • Oxycodone Urine Drug Screening Result Observation Profile
  • PCP Urine Drug Screening Result Observation Profile
  • PDMP Review Observation Profile
  • PDMP Review Procedure Profile
  • Pain Management Procedure Profile
  • Pain Treatment CarePlan Profile
  • Sickle Cell Encounter Diagnosis Condition Profile
  • Sickle Cell Problem List Health Concern Condition Profile
  • Subacute Pain Management MedicationRequest Profile
  • Subacute or Chronic Pain Management MedicationRequest Profile
  • Urine Drug Screening Result Observation Profile